HU CD21 BV421 b-LY4 100TST and 13 more items

Fisher Scientific Company LLC was awarded contract A207_PO-0422665-V3 by the University of Virginia on July 25, 2026, with a cumulative value of $4,740.08. The contract encompasses the procurement of laboratory reagents and biological research materials, including enzymatic products such as DNase I and RNase inhibitors, as well as monoclonal antibodies and immunological detection reagents. These materials support flow cytometry and immunological research applications, with specific focus on human cell surface markers including CD19, CD21, CD24, CD27, CD38, and CD138, among others.

The contract comprises fourteen line items totaling 4,736 units of materials, each priced at $1.00 per unit, delivered to the University of Virginia buyer in Virginia. The line items include fluorescently-labeled antibodies in various configurations (BV421, PE-CF594, APC-H7, FITC, and PerCP/Cy5.5), anti-human immunoglobulin detection reagents, and supporting enzymatic reagents necessary for molecular and cellular biology research. The materials are primarily consumable laboratory products essential for flow cytometric analysis and immunological assays within the University of Virginia's research operations.